"Passionate about improving cattle health & welfare through innovation, excellence & valued & trusted customer support."

News

One of the largest studies of its kind in the world has demonstrated that adding the long acting anti-inflammatory drug Metacam® (meloxicam) to antibiotic treatment of farmer-diagnosed clinical mastitis can reduce both Somatic Cell Count (SCC) and culling rates.  The study was carried out over 15 farms with a total of 11,163 cows across New Zealand, and enrolled almost 800 cows with clinical... Read More
Pressure on the industry As you may be aware from the media, there has been increasing discussion around the use of antibiotics on farms. Growing awareness of the agricultural industry’s extensive use of drugs that are important for the treatment of infectious disease in humans is driving change across Europe. Antimicrobials are becoming less effective in animals and man1, with bacteria that are... Read More

Pages

An educational service from Boehringer Ingelheim Limited, Vetmedica Division, the makers of Metacam®, Bovikalc®, Ubrolexin®, Ubro Yellow®, Ubro Red® and Mamyzin®.

Advice on the use of Metacam, Bovikalc or other therapies should be sought from your veterinary surgeon. Metacam contains meloxicam, UK: POM-V IE: POM. Bovikalc contains calcium chloride and calcium sulphate and is not a veterinary medicine which is subject to authorisation by the Irish Medicines Board. Further information available from Boehringer Ingelheim Limited, Vetmedica Division, Bracknell, Berkshire, RG12 8YS, UK. Email: vetmedica.uk@boehringer-ingelheim.com | Web: www.boehringer-ingelheim.co.uk

See our Terms of Use

Date of preparation: Jul 2013. AHD 7729. Use Medicines Responsibly (www.noah.co.uk/responsible)